Is the world ready for the next pandemic?

Focused Solutions

PROUDLY HOSTED BY

Wednesday 24 April, 11am - 12:30pm AEST
Breakout 3

SESSION DETAILS

The COVID-19 pandemic is one of the greatest global challenges in human history – a health, scientific and political challenge, causing upheaval across all of society. For the first time in 70 years, life expectancy in all regions has decreased from 2020. Globally, it is estimated over 30 million people have lost their lives (all-cause excess deaths) since the onset of the pandemic, and the cost to the global economy has been more than U$12 trillion. Moreover, COVID has had an indirect impact on health systems and set progress back on global health priorities such as childhood immunisation, maternal and child health, mental health and TB, HIV, and malaria. Long COVID is an urgent and under-recognised consequence of COVID-19, affecting at least 65 million people globally.

The draft of the WHO pandemic accord recognises the “catastrophic failure of the international community in showing solidarity and equity.”

The cost of this failure has been borne largely by low- and middle-income countries (LMICs) and in exacerbating existing inequities within countries. Over 1 million people are estimated to have died as a result of vaccine inequity.

Despite multiple previous expert reports and recommendations, the COVID-19 pandemic provides a galvanising moment to set path on a difference course if we are to prepare and prevent future pandemics and health emergencies.

This session will explore the system failures in the pandemic response where solutions and reform can prevent future pandemics. There will be a focus on the role of research and development, data for decision making and equitable access to tools and solutions.

Panel members will provide an update and discuss the political determinants of the pandemic, international and multi-sectoral collaboration and development and ratification of binding global health instruments – a new pandemic accord (treaty) and reform of the International Health Regulations.

SESSION DESCRIPTION

Brendan Crabb
Director and CEO, Burnet Institute, Co-Head, Malaria Virulence and Drug Discovery Group, Burnet Institute; Chair Australian Global Health Alliance; Chair Pacific Friends of Global Health

SESSION CHAIR

Helen Clark
Former Prime Minister of New Zealand, and Former Administrator of the United Nations Development Programme

Rolf Apweiler
Director, European Molecular Biology Laboratory-European Bioinformatics Institute

Allen Cheng
Director, Monash Infectious Diseases, Monash Health, Australia

Jodie McVernon
Professor and Director of Doherty Epidemiology, The Peter Doherty Institute for Infection and Immunity, Australia

Michael Baker
Professor, Department of Public Health, University of Otago, Wellington, Aotearoa New Zealand

Chang-Chuan Chan
Distinguished Professor, Global Health Program, College of Public Health, National Taiwan University

Arabella Koliwan
Director - Clinical Systems, Emergency Physician, St Johns Ambulance, Papua New Guinea

INVITED SPEAKERS